KILIÇKAP, S. Et Al. 2008. Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma. MEDICAL ONCOLOGY , vol.25, no.4 , 437-442.

KILIÇKAP, S., Yavuz, B., AKSOY, S., Sahiner, L., DİNÇER, M., HARPUTLUOĞLU, H., ... ERMAN, M.(2008). Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma. MEDICAL ONCOLOGY , vol.25, no.4, 437-442.

KILIÇKAP, SAADETTİN Et Al. "Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma," MEDICAL ONCOLOGY , vol.25, no.4, 437-442, 2008

KILIÇKAP, SAADETTİN Et Al. "Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma." MEDICAL ONCOLOGY , vol.25, no.4, pp.437-442, 2008

KILIÇKAP, S. Et Al. (2008) . "Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma." MEDICAL ONCOLOGY , vol.25, no.4, pp.437-442.

@article{article, author={SAADETTİN KILIÇKAP Et Al. }, title={Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma}, journal={MEDICAL ONCOLOGY}, year=2008, pages={437-442} }